Clinical Trial Update: Theophylline in Treating Cancer Patients With Shortness of Breath [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating theophylline for treating cancer patients with shortness of breath; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Complications in Cancer
• Quality of Life Impact in Cancer Patients

Drugs mentioned

• Theophylline (Theophylline)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Pulmonary Complications, Quality of Life | Phase 3 | Status: COMPLETED